Polymorphism of the cytochrome P450 (CYP) 2C9 gene in Japanese epileptic patients:: genetic analysis of the CYP2C9 locus

被引：119
|
作者：
Imai, J
Ieiri, I
Mamiya, K
Miyahara, S
Furuumi, H
Nanba, E
Yamane, M
Fukumaki, Y
Ninomiya, H
Tashiro, N
Otsubo, K
Higuchi, S
机构：
[1] Tottori Univ, Fac Med, Dept Hosp Pharm, Yonago, Tottori 6838504, Japan
[2] Tottori Univ, Ctr Gene Res, Yonago, Tottori 6838504, Japan
[3] Kyushu Univ, Inst Genet Informat, Higashi Ku, Fukuoka, Japan
[4] Kyushu Univ, Fac Med, Div Pharmaceut Sci, Higashi Ku, Fukuoka, Japan
[5] Kyushu Univ, Fac Med, Dept Neuropsychiat, Higashi Ku, Fukuoka, Japan
来源：
PHARMACOGENETICS | 2000年 / 10卷 / 01期
关键词：
CYP2C9; genetic analysis; polymorphism; new mutations; Japanese;
D O I：
10.1097/00008571-200002000-00011
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
[No abstract available]
引用
收藏
页码：85 / 89
页数：5
相关论文
共 50 条
  • [1] Genetic polymorphism of cytochrome P450s, CYP2C19, and CYP2C9 in a Japanese population
    Kimura, M
    Ieiri, I
    Mamiya, K
    Urae, F
    Higuchi, S
    THERAPEUTIC DRUG MONITORING, 1998, 20 (03) : 243 - 247
  • [2] Genetic analysis of CYP2C9 polymorphism in a Japanese population
    Nasu, K
    Kubota, T
    Ishizaki, T
    PHARMACOGENETICS, 1997, 7 (05): : 405 - 409
  • [3] Significance of CYP2C9 genetic polymorphism in inhibitory effect of Δ9-tetrahydrocannabinol on CYP2C9 activity
    Satoshi Yamaori
    Mika Kushihara
    Kyoko Koeda
    Ikuo Yamamoto
    Kazuhito Watanabe
    Forensic Toxicology, 2013, 31 : 70 - 75
  • [4] Significance of CYP2C9 genetic polymorphism in inhibitory effect of Δ9-tetrahydrocannabinol on CYP2C9 activity
    Yamaori, Satoshi
    Kushihara, Mika
    Koeda, Kyoko
    Yamamoto, Ikuo
    Watanabe, Kazuhito
    FORENSIC TOXICOLOGY, 2013, 31 (01) : 70 - 75
  • [5] Effect of different genetics variants: CYP2C9*2, CYP2C9*3 of cytochrome P-450 CYP2C9 and 1639G>A of the VKORC1 gene; On acenocoumarol requirement in Moroccan patients
    Smires, F. Z.
    Habbal, R.
    Moreau, C.
    Assaidi, A.
    Loriot, M. A.
    Nadifi, S.
    PATHOLOGIE BIOLOGIE, 2013, 61 (03): : 88 - 92
  • [6] Metabolism of steroids by cytochrome P450 2C9 variants
    Uno, Tomohide
    Nakano, Ryosuke
    Kitagawa, Risa
    Okada, Mai
    Kanamaru, Kengo
    Takenaka, Shinji
    Uno, Yuichi
    Imaishi, Hiromasa
    BIOPHARMACEUTICS & DRUG DISPOSITION, 2018, 39 (08) : 371 - 377
  • [7] Genetic polymorphism of CYP2C9 in a Vietnamese Kinh population
    Lee, SS
    Kim, KM
    Thi-Le, H
    Yea, SS
    Cha, IJ
    Shin, DG
    THERAPEUTIC DRUG MONITORING, 2005, 27 (02) : 208 - 210
  • [8] Polymorphism of the biotransformation gene cytochrome-450 2C9 in patients with tuberculosis
    Antonenko, P. B.
    Kresyun, V. I.
    MOLECULAR GENETICS MICROBIOLOGY AND VIROLOGY, 2014, 29 (03) : 110 - 114
  • [9] Polymorphism of the biotransformation gene cytochrome-450 2C9 in patients with tuberculosis
    P. B. Antonenko
    V. I. Kresyun
    Molecular Genetics, Microbiology and Virology, 2014, 29 : 110 - 114
  • [10] Systematic polymorphism analysis of the CYP2C9 gene in Chinese Han and Tibetan populations
    Wang, Yue-Wen
    Meng, Xiao-Hong
    Yan, Wei
    Zhang, Xiao-Qing
    Yang, Jin
    GENES & GENOMICS, 2012, 34 (03) : 291 - 297
12345